Common Side Effects of Cosentyx
Cosentyx (secukinumab), used for conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis in children aged 6 and up, often causes upper respiratory infections (cold-like symptoms) in about 15-20% of patients. Other frequent issues include diarrhea, oral herpes, and tonsillitis, affecting 5-10% of kids. These are usually mild and resolve without stopping treatment.[1][2]
Serious Risks Parents Should Watch For
Infections pose the biggest threat since Cosentyx suppresses the immune system—inflammatory bowel disease (like Crohn's) flares in 1-2% of cases, and rare cases of tuberculosis reactivation occur. Allergic reactions (rash, swelling, breathing trouble) hit less than 1%, but require immediate medical attention. Long-term use links to increased candida infections in the mouth or throat.[1][3]
Side Effects Specific to Children
Pediatric trials for plaque psoriasis (ages 6+) show similar profiles to adults, but kids under 6 lack approval. Growth delays or weight changes aren't directly linked, though monitoring is advised during studies. No unique pediatric risks beyond general immune suppression, but younger immune systems may heighten infection odds.[2][4]
How Long Do Side Effects Last?
Most common ones like respiratory infections or diarrhea start within weeks and last 1-2 weeks. Serious infections can persist longer if untreated. Injection-site reactions (redness, itching) fade in days. Full data from trials up to 52 weeks show no cumulative worsening.[1][3]
What Happens If My Child Gets an Infection?
Stop Cosentyx and call the doctor—screen for TB before starting and watch for fever, cough, or unexplained fatigue. Prophylactic antibiotics aren't routine, but doctors may prescribe them for recurrent issues. Hospitalization is rare but needed for severe cases.[2][5]
Differences from Adult Side Effects
Kids report slightly higher rates of nasopharyngitis (19% vs. 15% in adults) but fewer GI issues. Overall incidence matches adults, per FDA pediatric labeling.[4]
Tips for Parents Managing Treatment
Administer subcutaneous injections weekly at first, then monthly—rotate sites to avoid irritation. Pre-treat with antihistamines if history of allergies. Annual TB tests recommended. Report any new symptoms promptly; benefits often outweigh risks for moderate-to-severe disease.[1][5]
[1]: Cosentyx Prescribing Information (Novartis, FDA-approved 2023)
[2]: Cosentyx Safety in Pediatrics (Novartis Clinical Data)
[3]: FDA Post-Marketing Surveillance Report on Secukinumab
[4]: Pediatric Psoriasis Trial (CHMP Assessment)
[5]: American Academy of Dermatology Guidelines on Biologics in Kids